Related Experiment Videos
Infectious syphilis
1Department of Dermatology, New York University Medical Center, New York 10016.
Seminars in Dermatology
|December 1, 1994
Summary
Syphilis cases are at a 40-year high, challenging medical professionals with diverse symptoms. Human immunodeficiency virus co-infection may increase risks for neurosyphilis and treatment complications.
Area of Science:
- Infectious Diseases
- Public Health
- Dermatology
Background:
- Optimistic predictions regarding syphilis eradication have been invalidated by recent trends.
- Reported cases of infectious syphilis have reached a 40-year peak.
- Syphilis presents significant clinical challenges due to its varied manifestations.
Purpose of the Study:
- To highlight the persistent challenge of syphilis despite numerous publications.
- To examine the impact of human immunodeficiency virus (HIV) co-infection on syphilis presentation and outcomes.
- To identify potential risks for neurosyphilis and late complications in co-infected patients.
Main Methods:
- Review of recent epidemiological data on infectious syphilis.
- Analysis of clinical presentations and outcomes in syphilis patients.
- Comparative assessment of syphilis patients with and without HIV co-infection.
Main Results:
- Infectious syphilis rates are at their highest in four decades.
- HIV co-infection does not significantly alter syphilis stage, course, or serology in most cases.
- HIV-co-infected individuals face elevated risks for neurosyphilis and late complications, even with appropriate treatment.
Conclusions:
- Syphilis remains a significant public health concern requiring ongoing clinical attention.
- HIV co-infection necessitates careful monitoring for potential neurological and long-term complications of syphilis.
- Effective management strategies must address the complexities of syphilis, particularly in co-infected populations.